Latest news
Parents urged to vaccinate children amid flu, Covid-19 and RSV infection cases - South China Morning PostSouth China Morning Post · Sat, 08 Aug 2026 08:50:36 GMTFDA Reviews Clesrovimab for Second-Season RSV Prevention in High-Risk Children - Patient Care OnlinePatient Care Online · Sat, 08 Aug 2026 02:54:59 GMTClesrovimab shows comparable safety to palivizumab in high-risk infants across 2 RSV seasons - Contemporary PediatricsContemporary Pediatrics · Fri, 07 Aug 2026 17:56:30 GMTUS FDA accepts supplemental Biologics License Application for Merck’s Enflonsia - PMLiVEPMLiVE · Fri, 07 Aug 2026 10:55:00 GMTCo-Diagnostics files FDA 510(k) for flu and RSV PCR test - Medical Device NetworkMedical Device Network · Fri, 07 Aug 2026 10:08:21 GMTRespiratory syncytial virus (RSV) older adults vaccination coverage in England: June 2026 report - GOV.UKGOV.UK · Thu, 06 Aug 2026 23:19:44 GMTFDA Accepts Merck's Application to Expand Enflonsia into Second RSV Season - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:38 GMTFDA Accepts sBLA for Clesrovimab-cfor in Second RSV Season - HCPLiveHCPLive · Thu, 06 Aug 2026 16:30:47 GMT